Healius (ASX:HLSNB) - Stock Price, News & Analysis

HLSNB Stock Overview

Provides specialty diagnostic services to consumer and practitioners in Australia.

HLSNB fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings are forecast to grow 84.65% per year

Risk Analysis

Shares are highly illiquid

Shareholders have been diluted in the past year

Healius Limited Competitors

Integral Diagnostics

ASX:IDX

AU$601.2m

Australian Clinical Labs

ASX:ACL

AU$527.3m

Capitol Health

ASX:CAJ

AU$319.6m

Healthia

ASX:HLA

AU$252.1m

Price History & Performance

Summary of all time highs, changes and price drops for Healius
Historical stock prices
Current Share Price	AU$1.53
52 Week High	AU$1.60
52 Week Low	AU$1.40
Beta	0.76
11 Month Change	3.73%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-12.20%

Recent updates

Shareholder Returns

	HLSNB	AU Healthcare	AU Market
7D	0%	4.2%	0.1%
1Y	n/a	-18.2%	8.5%

Return vs Industry: Insufficient data to determine how HLSNB performed against the Australian Healthcare industry.

Return vs Market: Insufficient data to determine how HLSNB performed against the Australian Market.

Price Volatility

Is HLSNB's price volatile compared to industry and market?
HLSNB volatility
HLSNB Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.5%
Market Average Movement	8.4%
10% most volatile stocks in AU Market	16.2%
10% least volatile stocks in AU Market	3.2%

Stable Share Price: HLSNB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine HLSNB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1994	10,500	Maxine Jaquet	www.healius.com.au

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.

Healius Limited Fundamentals Summary

How do Healius's earnings and revenue compare to its market cap?
HLSNB fundamental statistics
Market cap	AU$926.67m
Earnings (TTM)	-AU$380.00m
Revenue (TTM)	AU$1.71b

0.5x

P/S Ratio

-2.4x

P/E Ratio

Is HLSNB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLSNB income statement (TTM)
Revenue	AU$1.71b
Cost of Revenue	AU$1.15b
Gross Profit	AU$554.30m
Other Expenses	AU$934.30m
Earnings	-AU$380.00m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.64
Gross Margin	32.47%
Net Profit Margin	-22.26%
Debt/Equity Ratio	37.3%

How did HLSNB perform over the long term?

See historical performance and comparison

Healius ASX:HLSNB Stock Report